Will you offer adjuvant olaparib to patients with somatic BRCA mutated breast cancer given that OlympiA only enrolled germline BRCA+?  

Do you perceive a difference between somatic vs germline BRCA mutations? 



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital
Do we know if adjuvant capecitabine is effective i...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution